Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia.

Expert opinion on drug discovery - 1 Oct 2017

Tripathi Rupal, Lee-Verges Eriong, Higashi Morihiro, Gimenez Neus, Rosich Laia, Lopez-Guerra Monica, Colomer Dolors

Abstract excerpt

INTRODUCTION: Next generation sequencing has provided a comprehensive understanding of the mutational landscape in chronic lymphocytic leukemia (CLL), and new drivers have been identified. Some of these drivers could be pharmacologically targeted to choose the most effective personalized therapy in each CLL patient. Areas covered: In this article, the authors uncover the potential role of new targeted therapies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Drug Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Discovery

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Molecular Targeted Therapy

Share to Precision Medicine

Share to Quality of Life

Share to Survival Rate

Source

Identifiers

PMID: 28776453
DOI: 10.1080/17460441.2017.1362387

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia.PMID 28776453Read ↗

Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies.Semantic proximity Read ↗

The clinical implications of gene mutations in chronic lymphocytic leukaemia.Semantic proximity Read ↗

Recent therapeutic advances in chronic lymphocytic leukemiaSemantic proximity Read ↗

Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape.Semantic proximity Read ↗

Emerging Therapies in CLL in the Era of Precision MedicineSemantic proximity Read ↗

Update on therapy of chronic lymphocytic leukemia.Semantic proximity Read ↗

The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome.Semantic proximity Read ↗

Molecular bases of chronic lymphocytic leukemia in light of new treatments.Semantic proximity Read ↗

Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic StrategiesSemantic proximity Read ↗

Therapy-driven clonal dynamics in chronic lymphocytic leukemia.Semantic proximity Read ↗

Chronic lymphocytic leukaemia genomics and the precision medicine era.Semantic proximity Read ↗

[The genetic landscape of chronic lymphocytic leukemia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.